CANN GROUP LIMITED — AGM Information 2019

Oct 28, 2019

CANN GROUP LIMITED ACN 603 949 739

Notice of Annual General Meeting and Explanatory Statement

TIME: 11.00am (Melbourne time)

DATE : Friday, 29 November 2019

PLACE: Exhibition Room at the offices of William Buck, Level 20, 181 William Street, Melbourne VIC 3000

This Notice of Meeting and Explanatory Statement should be read in its entirety

If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser without delay.

29 October 2019

Dear Shareholder

ANNUAL GENERAL MEETING

I am pleased to invite you to attend the Annual General Meeting of Cann Group Limited to be held at 11.00am on Friday 29 November 2019, in the Exhibition Room at the offices of William Buck, Level 20, 181 William Street, Melbourne and have enclosed the Notice of Annual General Meeting and Explanatory Statement.

If you are unable to attend the meeting in person, I encourage you to return the enclosed proxy form or to cast your vote online in accordance with the instructions contained in the Notice of Annual General Meeting. The proxy form should be returned in the envelope provided, or faxed to our Share Registry on 02 9287 0309 (within Australia) or +61 2 9287 0309 (outside Australia), so that it is received by 11.00am on Wednesday 27 November 2019.

Both I and Mr Peter Crock, Cann's Chief Executive Officer, will be making presentations at the meeting regarding the Company's operations including the developments at the Mildura facility presently under construction.

I look forward to your attendance at the meeting.

Yours faithfully

Allan McCallum Chairman

Notice of Annual General Meeting 2019

Notice is hereby given that the Annual General Meeting of Cann Group Limited ABN 25 603 949 739 ("the Company") will be held in the Exhibition Room at the offices of William Buck, Level 20, 181 William Street, Melbourne at 11am on Friday 29 November 2019 to transact the business set out below.

Members should refer to the accompanying Explanatory Statement for further information concerning the business to be transacted at this meeting.

Business of the Annual General Meeting

1. Financial Statements and Reports

To receive the financial report, directors' report and auditor's report for the Company and its controlled entities for the financial year ended 30 June 2019.

(Please note that no resolution will be required to be passed on this matter and there is no requirement for shareholders to approve these reports).

2. Adoption of Remuneration Report

To consider and, if thought fit, to pass the following non-binding advisory resolution as an ordinary resolution:

"That the Remuneration Report for the financial year ending 30 June 2019 be adopted."

(Please note that this resolution is advisory only and does not bind the Company or the Directors) (Refer to How To Vote section for Voting Exclusions applying to this resolution).

3. Re-election of Director

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

"That Mr Allan McCallum, a Director who retires from office in accordance with the Company's Constitution and being eligible, be re-elected a Director of the Company."

4. Re-election of Director

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

"That Mr Douglas Rathbone, a Director who retires from office in accordance with the Company's Constitution and being eligible, be re-elected a Director of the Company."

5. Ratification of prior issue of Shares

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

"That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 91,164 Shares to the Commonwealth Scientific and Industrial Research Organisation (CSIRO) under Listing Rule 7.1 on the terms and conditions set out in the Explanatory Statement.

(Refer to How To Vote section for Voting Exclusions applying to this resolution).

6. Ratification of prior issue of Shares

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

"That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 67,538 Shares to the Commonwealth Scientific and Industrial Research Organisation (CSIRO) under Listing Rule 7.1 on the terms and conditions set out in the Explanatory Statement.

(Refer to How To Vote section for Voting Exclusions applying to this resolution).

7. Approval of Long-Term Incentive Plan

To consider and, if thought fit, to pass the following resolution as an ordinary resolution: "That:

• (a) the Cann Group Limited Long Term Incentive Plan for employees of the Company ("2019 Long-Term Incentive Plan"), a summary of the terms of which are described in the Explanatory Statement which form part of this Notice of Annual General Meeting, be approved for the purposes of sections 260C(4) of the Corporations Act and for all other purposes; and
• (b) the grant and issue of all securities under the 2019 Long-Term Incentive Plan, a summary of the terms of which are described in the Explanatory Statement which form part of this Notice of Annual General Meeting, be approved as an exception to ASX Listing Rule 7.1 for the purposes of Exception 9(b) of Listing Rule 7.2 and for all other purposes."

(Refer to How To Vote section for Voting Exclusions applying to this resolution).

8. Approval of 10% placement capacity for 12 months

To consider and, if thought fit, to pass the following resolution as a special resolution:

"That, for the purpose of ASX Listing Rule 7.1A and for all other purposes, approval is given for the issue of Equity Securities totaling up to 10% of the issued capital, calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Notes."

(Refer to How To Vote section for Voting Exclusions applying to this resolution).

By Order of the Board

Richard Baker Company Secretary 29 October 2019

HOW TO VOTE

Voting entitlement

The Board has determined in accordance with regulation 7.11.37 of the Corporations Regulations that for the purpose of voting at the Annual General Meeting, shares will be taken to be held by those persons who hold them at 7.00pm (AEDT) on Wednesday 27 November 2019. This means that if you are not the registered holder of a share at that time you will not be entitled to vote at the Annual General Meeting in respect of that share.

Attending the Annual General Meeting

If you attend the Annual General Meeting, please bring your personalised proxy form with you. The barcode at the top of the form will help you to register. If you do not bring your form with you, you will still be able to attend the Annual General Meeting but representatives from Link Market Services Limited will need to verify your identity. You will be able to register from 10.30am on the day of the Annual General Meeting.

Voting by proxy

Each shareholder who is entitled to attend and vote at the Annual General Meeting may appoint a proxy to attend and vote on behalf of that shareholder as an alternative to attending the Annual General Meeting in person. The proxy need not be a shareholder of the Company.

Where a shareholder appoints more than one representative, proxy or attorney, those appointees are entitled to vote on a poll but not on a show of hands. A shareholder who is entitled to cast two or more votes may appoint one or two proxies and may specify the proportion or number of votes that each proxy is appointed to exercise. If a shareholder appoints two proxies and the appointment does not specify the proportion, or number, of shareholder's votes, each proxy may exercise half the shareholder's votes (disregarding fractions).

Directed and Undirected Proxies

If you choose to appoint a proxy, the Board encourages you to direct your proxy how to vote on each resolution, by marking either 'For', 'Against' or 'Abstain' for the item of business on the proxy form.

If you sign the enclosed proxy form and do not appoint the chairperson or specify an individual or body corporate as your proxy, you will have appointed the chairperson as your proxy by default. In that case, your shares will be voted on the proposed resolutions in accordance with your directions on the proxy form.

If you do not direct the chairperson how to vote your shares, the chairperson will vote undirected proxies on, and in favour of, all of the proposed resolutions including Item 2 (Adoption of Remuneration Report), Items 5 and 6 (Ratification of prior issues), Item 7 (Approval of Long-Term Incentive Plan) and Item 8 (Approval of 10% placement capacity for 12 months). Where the chairperson is appointed as your proxy, you will be taken to have expressly authorised the chairperson to cast your votes on Item 2 (Adoption of Remuneration Report) ), Items 5 and 6 (Ratification of prior issues), Item 7 (Approval of Long-Term Incentive Plan) and Item 8 (Approval of 10% placement capacity for 12 months).

If you appoint as your proxy any other Director, or any of their closely related parties, they will vote undirected proxies in favour of all of the proposed resolutions except Item 2 (Adoption of Remuneration Report) and Item 7 (Approval of Long-Term Incentive Plan). They will not cast any votes in respect of Item 2 (Adoption of Remuneration Report) and Item 7 (Approval of Long-Term Incentive Plan) that arise from undirected proxies.

"Key management personnel" of the Company for the financial year ended 30 June 2019 are identified in the Remuneration Report, which forms part of the Company's 2019 Annual Report. The "closely related parties" of the Company's Key Management Personnel are defined in the Corporations Act 2001 (Cth) ("Corporations Act"), and include certain of their family members, dependants and companies they control.

You may appoint the chairperson of the Annual General Meeting as your proxy by nominating him in the proxy form. If you return your proxy form but do not nominate the identity of your proxy, the chairperson will automatically be your proxy. If you return your proxy form but your nominated proxy does not attend the Annual General Meeting, then your proxy will revert to the chairperson. For a resolution determined on a poll, if your nominated proxy is either not recorded as attending the Annual General Meeting or does not vote on the resolution, the chairperson is taken, before voting on the resolution closes, to have been appointed as your proxy for the purposes of voting on the resolution.

Lodging your Proxy

A proxy appointment form is enclosed in this Notice of Annual General Meeting. For the appointment of a proxy to be effective for the Annual General Meeting, the following documents must be received no later than 48 hours before the scheduled time for the Annual General Meeting; that is by 11.00am on Wednesday 27 November 2019:

(a) the proxy's appointment; and

(b) if the appointment is signed by the appointor's attorney - the authority under which the appointment was signed or a certified copy of the authority.

Documents may be lodged online, by posting, delivery or facsimile to the Company's Share Registry at:

Link Market Services Limited

Online: www.linkmarketservices.com.au

By Post:

Cann Group Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia

Delivery to Link Market Services Limited*: 1A Homebush Bay Drive Rhodes NSW 2138

or

Level 12 680 George Street Sydney NSW 2000

* During business hours (Monday to Friday, 9.00am-5.00pm)

Facsimile: (+61 2) 9287 0309

If you have any queries and wish to contact Link Market Services Limited, please call (+61) 1300 554 474.

Bodies corporate

A body corporate may appoint an individual as its representative to exercise all or any of the powers the body corporate may exercise at the Annual General Meeting. The appointment may be a standing one. Unless otherwise specified in the appointment, the representative may exercise, on the body corporate's behalf, all of the powers that the body corporate could exercise at the Annual General Meeting or in voting on a resolution. Unless it has previously been given to the Company, the representative should bring evidence of their appointment to the meeting, together with any authority under which it is signed. The appointment must comply with Section 250D of the Corporations Act.

Attorneys

A shareholder may appoint an attorney to vote on their behalf. To be effective for the meeting, the instrument effecting the appointment (or certified copy of it) must be received no later than 48 hours before the scheduled time for the Annual General Meeting; that is by 11.00am (AEDT) on Wednesday 27 November 2019.

Voting exclusion statements

Item 2 – Adoption of Remuneration Report

The Company will disregard any votes cast in favour of the resolution by or on behalf of:

• (a) a member of the Key Management Personnel whose remuneration is included in the 2019 Remuneration Report is excluded from voting; and
• (b) any closely related party of such a Key Management Personnel.

However, the Company need not disregard a vote if:

• (a) it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or
• (b) it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

For the purposes of this voting exclusion, Key Management Personnel are the Directors and those others persons who have authority and responsibility for planning, directing and controlling the activities of the Company, either directly or indirectly, as listed in the Remuneration Report for the year ended 30 June 2019. A "closely related party" of such a Key Management Personnel means:

• a spouse or child of such a Key Management Personnel;
• a child of such a Key Management Personnel;
• a dependent of such a Key Management Personnel or of the spouse such a Key Management Personnel; or
• a company such a Key Management Personnel controls.

Items 5 and 6 – Ratification of prior issues of Shares

The Company will disregard any votes cast in favour of this Resolution by, or on behalf of, any person who participated in the issue or an associate of those persons.

However, the Company need not disregard a vote if:

• (a) it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or
• (b) it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides

Item 7 – Approval of Long-Term Incentive Plan

The Company will disregard any votes cast in favour of the resolution by or on behalf of:

• (a) an Eligible Employee, including a Director, of the Company (except one who is ineligible to participate in the Long-Term Incentive Plan in relation to the Company); and
• (b) any closely related party of such an Eligible Employee or Director.

However, the Company need not disregard a vote if:

• (a) it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or
• (b) it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

For the purposes of this voting exclusion, Eligible Employee means a full time or part time employee of the Company. A "closely related party" of such an Eligible Employee means:

• a spouse or child of such an Eligible Employee;
• a child of such an Eligible Employee;
• a dependent of such an Eligible Employee or of the spouse such an Eligible Employee; or
• a company such an Eligible Employee.

Item 8 – Approval of 10% placement capacity for 12 months

In accordance with the ASX Listing Rules, the Company will disregard any votes cast in favour of this this resolution by any person who is expected to participate in the issue of Equity Securities under this resolution and any person who will obtain a material benefit, except a benefit solely in the capacity of a holder of ordinary securities in the Company, if this resolution is passed, and any associates of those persons.

However, in relation to this resolution, the Company need not disregard a vote if:

• (a) it is cast by a person as proxy for a person who is entitled to vote in accordance with the directions on the proxy form; or
• (b) it is cast by the chairperson as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

EXPLANATORY STATEMENT

This Explanatory Statement, which accompany and form part of the Notice of Annual General Meeting, have been prepared to assist shareholders with their consideration of the resolutions set out in the Notice of Annual General Meeting dated 10 October 2017.

1. Financial Statements and Reports

During this item there will be a reasonable opportunity for shareholders to ask questions and comment on the financial report, directors' report, auditor's report for the Company and its controlled entities for the for the financial year ended 30 June 2019, and on the business, operations and management of the Company. No resolution will be required to be passed on this matter.

Further, in accordance with section 250PA of the Corporations Act, a shareholder who is entitled to cast a vote at the Annual General Meeting may submit a written question to the Company's auditor if the question is relevant to:

• (a) the content of the auditor's report; or
• (b) the conduct of the audit of the financial report,

by giving the question to the Company by no later than Wednesday 27 November 2019. The auditor will then compile the questions relevant to the content of the Auditor's Report or the conduct of the audit of the Financial Report into a question list. At or before the start of the Annual General Meeting, the Company will make the question list reasonably available to the Shareholders attending the Annual General Meeting.

Shareholders who have not elected to receive a hard copy of the Company's 2019 Annual Report can view or download it from the Company's website at investors.canngrouplimited.com/investors/?page=annual-reports.

2. Adoption of Remuneration Report

The Remuneration Report for the year ended 30 June 2019 is set out in the 2019 Annual Report.

Pursuant to section 250R(2) of the Corporations Act, a resolution that the Remuneration Report be adopted must be put to the vote at the Company's Annual General Meeting. The vote on the proposed resolution is advisory only and does not bind the Company or its Directors. However, the Board will take the outcome of the vote into consideration when reviewing the Company's remuneration practices and policies.

Pursuant to the Corporations Act, if 25% or more votes that are cast are voted against the adoption of the Remuneration Report at two consecutive AGM's, shareholders will be required to vote at the second of those AGM's on a resolution (a "spill resolution") to decide whether a general meeting of shareholders is to be held within 90 days of the date of that AGM to consider the election of the Company's Directors. If a spill resolution is passed (that is, more than 50% if votes cast in favour), all of the Company's Directors will cease to hold office at the end of that General Meeting, unless re-elected at that meeting.

During this item there will be a reasonable opportunity for shareholders at the meeting to comment on and ask questions about the Remuneration Report which is contained within the 2019 Annual Report.

The chairman of the meeting intends to vote undirected proxies in favour of the adoption of the Remuneration Report.

Directors' Recommendation

The Directors unanimously recommend that shareholders vote in FAVOUR of adopting the Remuneration Report.

Item 3 Re-election of Director

Mr McCallum was appointed as a Director on 30 January 2015 and subsequently re-elected as a Director by shareholders at the 2016 Annual General Meeting and isrequired to retire from office under the Company's Constitution. Being eligible, he has offered himself for re-election and is seeking re-election by shareholders at this Annual General Meeting. His biographical details are set out below:

Allan McCallum, Dip. Ag Science, FAICD

An experienced public company director in agribusiness and healthcare who has strong ethics, proven leadership capabilities and extensive experience in strategy development and implementation and mergers and acquisitions. Allan is the current Chair of Tassal Group Ltd (ASX TGR) from 7 October 2003 Australia's largest producer of Atlantic salmon. His previous board roles include Medical Developments International Ltd (ASX MVP) from 27 October 2003 to 17 December 2018, Incitec Pivot Ltd (ASX IPL) from 30 January 1998 to 19 December 2013 and Graincorp Ltd (ASX GNR) from 26 February 1998 to 26 August 2005.

The chairman of the meeting intends to vote undirected proxies in favour of the re-election of Mr McCallum.

Directors' Recommendation

The non-candidate Directors recommend that shareholders vote in FAVOUR of the re-election of Mr McCallum.

4. Re-election of Director

Mr Rathbone was appointed as a Director on 16 March 2015 and subsequently re-elected as a Director by shareholders at the 2017 Annual General Meeting and is required to retire from office under the Company's Constitution. Being eligible, he has offered himself for re-election and is seeking re-election by shareholders at this Annual General Meeting. His biographical details are set out below:

Douglas Rathbone, AM, FATSE, FI ChemE, ARMIT B Comm, TTC

An experienced public company director, he is the former Managing Director and CEO of Nufarm Limited (ASX NUF) from 21 August 1987 to 4 February 2015 – an ASX 200 listed company and is a former Board member of the FERNZ Corporation and the CSIRO. He Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Leaf Resources Ltd (ASX LER) from 1 November 2016 and Chairman since 1 April 2018, Go Resources, Queenscliff Harbour Pty Ltd and AgBiTech. He is also a former member of the RABO Bank Advisory Board, an Honorary Life Governor of the Royal Children's Hospital and a former Director of the Burnett Centre for Medical Research. Doug brings to the Board experienced management and corporate governance skills together with a passion to grow the business having successfully transformed Nufarm to become one of the world's leading crop protection and seed companies with an extensive global footprint.

The chairman of the meeting intends to vote undirected proxies in favour of the re-election of Mr Rathbone.

Directors' Recommendation

The non-candidate Directors recommend that shareholders vote in FAVOUR of the re-election of Mr Rathbone.

5. Ratification of prior issue of Shares

Resolution 5 seeks Shareholder ratification pursuant to Listing Rule 7.4 for the previous issue of Shares which the Company issued within the last 12 months without obtaining prior Shareholder approval.

Listing Rule 7.1

ASX Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue more equity securities during any 12-month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12-month period without shareholder approval.

Listing Rule 7.4

ASX Listing Rule 7.4 provides an exception to Listing Rule 7.1. It provided that where a company in a general meeting ratifies the previous issue of Securities made pursuant to Listing Rule 7.1 (and provided that the previous issue did not breach Listing Rule 7.1), those securities will be deemed to have been made with Shareholder approval for the purpose of Listing Rule 7.1 as applicable.

Specific information required by Listing Rule 7.5

Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to the ratification of the issue the Shares under Resolution 5:

• (a) a total of 91,164 Shares were issued on 24 December 2018;
• (b) the Shares were issued for \$2.20 per Share;
• (c) the Shares were issued as fully paid ordinary shares in the capital of the Company and rank equally in all respects with the Company's existing Shares on issue;
• (d) the Shares were issued to the Commonwealth Scientific and Industrial Research Organisation (CSIRO);
• (e) the Shares were issued as part payment of an invoice from the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for research and development services provided to the Company – the Company and CSIRO entered into a Research Services Umbrella Agreement and Share Purchase Agreement, both on 24 October 2018, whereby fifty percent (50%) of the invoices for research and development services provided to the Company by CSIRO under the Research Services Umbrella Agreement would be settled by the issuing of New Shares to CSIRO (exclusive of GST) and the balance settled by cash; and
• (f) a voting exclusion statement is included in the Notice.

6. Ratification of prior issue of Shares

Resolution 6 seeks Shareholder ratification pursuant to Listing Rule 7.4 for the previous issue of Shares which the Company issued within the last 12 months without obtaining prior Shareholder approval.

Listing Rule 7.1

ASX Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue more equity securities during any 12-month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12-month period without shareholder approval.

Listing Rule 7.4

ASX Listing Rule 7.4 provides an exception to Listing Rule 7.1. It provided that where a company in a general meeting ratifies the previous issue of Securities made pursuant to Listing Rule 7.1 (and provided that the previous issue did not breach Listing Rule 7.1), those securities will be deemed to have been made with Shareholder approval for the purpose of Listing Rule 7.1 as applicable.

Specific information required by Listing Rule 7.5

Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to the ratification of the issue the Shares under Resolution 6:

• (a) a total of 67,538 Shares were issued on 4 October 2019;
• (b) the Shares were issued for \$2.08 per Share;
• (c) the Shares were issued as fully paid ordinary shares in the capital of the Company and rank equally in all respects with the Company's existing Shares on issue;
• (d) the Shares were issued to the Commonwealth Scientific and Industrial Research Organisation (CSIRO);
• (e) the Shares were issued as part payment of an invoice from the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for research and development services provided to the Company – the Company and CSIRO entered into a Research Services Umbrella Agreement and Share Purchase Agreement, both on 24 October 2018, whereby fifty percent (50%) of the invoices for research and development services provided to the Company by CSIRO under the Research Services Umbrella Agreement would be settled by the issuing of New Shares to CSIRO (exclusive of GST) and the balance settled by cash; and
• (f) a voting exclusion statement is included in the Notice.

7. Approval of Cann Group Limited 2019 Long-Term Incentive Plan

This resolution seeks shareholder approval for the Cann Group Limited 2019 Long-Term Incentive Plan ("LTIP" or "Plan") for the purposes of ASX Listing Rule 7.2 exception 9(b), the Corporations Act and for all other purposes.

The Company wishes to establish the new LTIP pursuant to which it can offer Performance Rights to eligible employees (being full time or part time employees of the Company) (this does not include the Non-Executive Directors of the Company). The Company has an administrator or trustee for the purposes of the Plan to administer the LTIP ("Plan Administrator").

The purpose of LTIP is to ensure that the Company has appropriate mechanisms to continue to attract, motivate and retain the services of employees of a high calibre and to improve the longer-term performance of the Company. The LTIP is designed to align the remuneration of the participants in the LTIP with the long- term interests of the Company's shareholders. The alignment of interests is important in ensuring that participants in the LTIP are focused on achieving particular milestones, as determined by the Board, while the Company is able to attract and retain the best employees.

The Board, as considered by the Company's Remuneration Committee, will seek to ensure that the granting of Performance Rights to participants under the LTIP is made at levels that will appropriately position their total remuneration in the market to ensure remuneration remains reasonable and is appropriate having regard to the circumstances of Company.

Under the LTIP, the Board may offer to eligible employees the opportunity to be granted Performance Rights in the Company as the Board may decide and on the terms set out in the rules of the LTIP, a summary of which follows below. The LTIP provides for the granting of Performance Rights which will vest if the applicable Performance Conditions are satisfied. On vesting, each Performance Right entitles the participant to the issue or transfer of one fully paid ordinary share in the Company ("Share").

Under the LTIP, subject to the satisfaction of the applicable performance conditions, the Company will allocate the relevant number of Shares to which a participant is entitled under the terms of the LTIP by issuing that number of Shares to the participant or by procuring the Plan Administrator to acquire that number of Shares (whether by subscription or an on-market or off-market acquisition) on behalf of the participant. Where allocated Shares are acquired by the Plan Administrator on behalf of a participant, the Company will provide the necessary funding to the Plan Administrator in order to enable it make such acquisition and pay any associated costs including any brokerage fees. No securities have been issued the Plan as at the date of this Meeting.

If the performance conditions applicable to a participant are not met, within the applicable performance period not exceeding 30 June 2022, then the Performance Rights held by that participant will lapse.

In addition, a copy of the LTIP is available for review by Shareholders at the registered office of the Company until the date of the Meeting. Shareholders are invited to contact the Company if they have any queries or concerns.

ASX Listing Rule 7.1

ASX Listing Rule 7.1 provides that a company must not, subject to specific exceptions, issue or agree to issue more equity securities during any 12-month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12-month period without shareholder approval.

If this resolution is passed, the Company will be able to allocate Performance Rights (in relation to a maximum performance period of 3 years commencing on 1 July 2019 and ending on 30 June 2022) and the associated underlying Shares under the LTIP to participants without affecting the Company's ability to separately issue up to 15% of its total ordinary shares in any 12-month period (without having to obtain further shareholder approval). The Directors believe this will provide the Company with the flexibility necessary to raise additional capital as and when appropriate.

Accordingly, shareholders are asked to approve the Plan pursuant to which performance rights are able be granted, and all resultant Shares that are able to be allocated that result from the vesting of any of the performance rights, to participants in the Plan in accordance with the terms of the Plan as an exception to ASX Listing Rule 7.1 (Exception 9(b) in ASX Listing Rule 7.2) within the three years of the Plan being approved by shareholders.

Approval for the purposes of the Corporations Act – Financial Assistance

Under Section 260A of the Corporations Act provides that a company may financially assist a person to acquire shares in the company or a holding company of the company only if:

• (a) giving the assistance does not materially prejudice:
• (i) the interests of the company or its shareholders; or
• (ii) the company's ability to pay its creditors; or
• (b) the assistance is approved by shareholders under section 260B; or
• (c) the assistance is exempted under section 260C.

Section 260C of the Corporations Act provides for certain specific instances of exempted financial assistance, including a special exemption for employee share schemes that have been approved by a resolution passed at a general meeting of the company (section 260C(4)).

To the extent that the Company provides funds to the Plan Administrator of the LTIP to acquire Shares (and pay any associated costs) on behalf of participants under the LTIP, the Company will be providing financial assistance for the purposes of section 260A.

Whilst the Directors do not believe that the provision of this financial assistance will materially prejudice the interests of the Company or its shareholders or the Company's ability to pay its creditors, the Directors have recommended that the shareholders approve the LTIP to ensure that the LTIP qualifies for the special exemption under section 260C(4) of the Corporations Act and for all other purposes of any other relevant provisions of the Corporations Act.

The chairman of the meeting intends to vote undirected proxies in favour of this resolution.

Directors' Recommendation

The Directors unanimously recommend that shareholders vote in FAVOUR of this resolution.

A summary of the terms of the LTIP is set out below.

Summary of Cann Group Limited Long-Term Incentive Plan

Eligible Employee and	Eligible Employee means a full time or part time employee of the Company who is invited by the Board to
Participant	participate in the LTIP. A Participant is an Eligible Employee whose application has been accepted and has
	been granted Performance Rights.
Performance Right	Means a right to be allocated a Share under the Plan.
Performance	Performance Condition means, in relation to a Performance Right, the performance conditions prescribed
Condition and	by the Board that must be satisfied as a condition for a Participant to be allocated a Share in respect of a
Performance Period	Performance Right.

	Performance Period means the period of time prescribed by the Board over which the Performance
	Conditions must be satisfied as a condition for a Participant to be allocated a Share in respect of a
	Performance Right. The maximum end date for a Performance Period under the Plan will be 30 June 2022.
Purpose	The purpose of the LTIP is to:
	(a) to attract, motivate and retain Eligible Employees;
	(b) to provide an incentive to Eligible Employees to drive continuing improvement in the Company's
	performance;
	(c) to provide market competitive reward mechanisms in line with the expectations of Australian
	shareholders having regard to the Company's circumstances; and
	(d) to provide Eligible Employees with the opportunity to acquire an ownership interest in the
	Company.
LTIP Administration	The LTIP will be administered by the Board or the Plan Administrator. The Board may exercise any power of
	discretion conferred on it by the LTIP rules in its sole and absolute discretion. The Board may delegate its
	powers and discretion arising under the LTIP. The Plan Administrator means the person or entity selected
	by the Board to carry out the day to day administration of the Plan and to perform the functions allocated
	to that role for the purposes of the LTIP rules.
Eligibility	The Board may in its absolute discretion make an Offer to an Eligible Employee on the terms and conditions
	determined by the Board.
Offer and application	An Offer to the Eligible Employee must be in writing and specify:
	(a) the maximum number of Performance Rights which the Eligible Employee may apply for;
	(b) any applicable performance conditions and the performance period;
	(c) the minimum holding periods (if any) in relation to any or all of the Shares allocated; and
	(d) any other terms and conditions relating to the Offer which in the opinion of the Board are fair
	and reasonable but not inconsistent with the LTIP rules.
	The Application must: (a) be in writing; and
	(b) be completed in the name of the Eligible Employee and not in the name of anyone else.
Performance Rights	The Performance Rights granted under the Plan are personal to the participant and cannot be sold,
not transferable	transferred, mortgaged, charged, hedged, made subject to any margin lending arrangement or otherwise
	disposed of dealt with or encumbered in any way. Breach of this provision will result in the Performance
	Rights lapsing immediately, so that no Shares will be allocated in respect of those Performance Rights.
Allocation of Shares	If the Performance Conditions applicable to Performance Rights held by a Participant are satisfied in whole
	or in part over the Performance Period(s) applicable to those Performance Rights, the Company must
	allocate to the Participant the number of Shares to which the Participant is entitled under the terms of the
	Offer, by
	(a) issuing that number of Shares, or
	(b) procuring that the Plan Administrator acquires that number of Shares.
	Shares allocated are to be acquired by the Plan Administrator and registered in the name of that Participant
	but subject to a Holding Lock to ensure that the Shares are held in the Plan subject to the LTIP rules. The
	Participant shall be the beneficial owner of the Shares.
	If the Performance Conditions applicable to Performance Rights held by a Participant are not satisfied over
	the Performance Period(s) applicable to those Performance Rights, those Performance Rights will lapse and
	the Participant will be treated as having never held any right or interest in those Performance Rights.
Acquisition Price	A participant will not be required to pay for any Performance Rights or for any resultant or underlying
	Shares allocated under the Plan that result from the vesting of any of the Performance Rights. The
	Company will meet all of the acquisition costs it or the Plan Administrator incurs in allocating the Shares to
	which the participant may become entitled on vesting of Performance Rights under the Plan.

Maximum Number of	Performance rights and the resultant or underlying Shares must not be issued under this Plan if the number
Performance Rights	of Shares to be issued when aggregated with:
and Shares	(a) the number of Shares that would be issued if each outstanding offer with respect to Shares,
	units of Shares and options (including performance rights) to acquire unissued Shares or units of
	Shares, being offers made or options acquired pursuant to an employee share or option scheme
	extended only to employees or directors of the Company and its associated bodies corporate,
	were accepted or exercised (as the case may be); and
	(b) the number of Shares issued during the previous 5 years pursuant to any employee share or
	option scheme extended only to employees or directors of the Company and its associated
	bodies corporate, but disregarding any offer made, or option acquired or Share issued by way of
	or as a result of:
	(c) an offer to a person situated at the time of receipt of the offer outside Australia;
	(d) an offer that did not need disclosure to investors because of section 708 of the Corporations Act
	2001;
	(e) an offer that did not require the giving of a Product Disclosure Statement because of section
	1012D of the Corporations Act 2001;
	(f) an offer made under a disclosure document or Product Disclosure Statement,
Disposal Restrictions	would exceed 5% of the total number of issued Shares as at the time of the offer. A Share allocated to a participant must not be sold, transferred, mortgaged, charged or otherwise disposed
and Restriction	of, deal with or encumber unless the participant has submitted a Notice of Withdrawal and such notice has
Period	been approved or deemed to have been approved. A Notice of Withdrawal may be submitted following the
	earlier of:
	(a) the time the participant receives written consent from the Board to the request made by the
	participant for the sale or transfer of Shares under the LTIP; or
	(b) a capital event.
	A Notice of Withdrawal is deemed to have been submitted and approved immediately upon:
	(a) the participant ceasing to be an employee; or
	(b) the seventh anniversary of the grant date of the Performance Rights in respect of which the
	Shares have been allocated.
	The Company may apply a holding lock for the purpose of preventing a breach of the abovementioned
	Disposal Restrictions, subject to compliance with the Australian Securities Exchange Listing Rules. The
	Company may apply a holding lock to prevent any Share being sold, transferred, withdrawn, mortgaged,
	charged encumbered or otherwise disposed of.
Rights attaching to	Shares allocated under the LTIP rank equally with all other existing Shares in all respects including voting
Shares	rights and entitlement to participate in dividends and in future rights and bonus issues.
Cessation of	Generally, if a participant ceases to be an employee of the Company before the end of a Performance
employment	Period the Performance Rights will lapse.
	Subject to the absolute discretion of the Board to determine otherwise, where a participant ceases to be an
	employee of the Company after the first 12 months of a Performance Period by reason of retirement,
	redundancy, death or total and permanent disablement, the participant will be allocated Shares for the
	Performance Rights he or she holds in relation to that Performance Period on a pro-rata basis according to
	the proportion of the Performance Period completed as at the cessation date and subject to satisfaction of
	the relevant Performance Conditions over the duration of the Performance Period.
Capital Event/Change	Subject to the absolute discretion of the Board to determine otherwise, if a Capital Event (i.e. change of
of Control	control by share acquisition) or other similar event occurs before the end of a Performance Period, a
	participant will be allocated Shares for the Performance Rights he or she holds in relation to that
	Performance Period on a pro-rata basis according to the proportion of the Performance Period completed
	as at the date of the Capital Event and subject to satisfaction of the relevant Performance Conditions over the period from the start of the Performance Period to the date of the Capital Event.

Forfeiture of	All Performance Rights will lapse and all Shares a participant holds in the Plan will be forfeited if he or she is
Performance Rights	dismissed for cause or if the Board determines that the participant has acted fraudulently or dishonestly, or
and Shares	are in serious breach of duty to the Company, or have committed any act of harassment or discrimination,
	or in the Board's reasonable opinion the participant has brought the Company into disrepute or otherwise
	caused it damage or harm.
No quotation of	The Performance Rights will not be quoted on the ASX.
Performance Rights
Waiver of	Subject to the ASX Listing Rules, the Board may, in relation to a Performance Right, waive in whole or in
Performance	part, on terms it considers appropriate, any of the Performance Conditions or other terms or conditions
Conditions	applicable to the Performance Right.
Amendments to the	The Board may at any time amend all or any of the provisions of the LTIP subject to the consent of 75% of
LTIP	all Participants, if the amendment would prejudicially affect the rights of the Participants, except the Board
	may make an amendment primarily:
	(a) for the purpose of complying with present or future law;
	(b) to correct any manifest error or mistake;
	(c) to take into consideration possible adverse tax implications in respect of the LTIP; or
	(d) to enable the Company to comply with the Listing Rules or instruments of relief issued by the
	Australian Securities and Investments Commission from time to time relating to employee share
	schemes.
Termination of the	The Board of the Company may, in its absolute discretion, terminate the LTIP in whole or in part in respect
LTIP	of some or all of the Eligible Employees, without any liability whatsoever on the Company, however no
	action may be taken that would prejudicially affect the existing rights of participants under the LTIP rules.

Further information regarding the Company's corporate governance arrangements and the Board's role can be found on the Company's website at investors.canngrouplimited.com/investors/.

8. Approval of 10% placement capacity for 12 months

General

ASX Listing Rule 7.1A provides that an Eligible Entity may seek Shareholder approval at its Annual General Meeting to allow it to issue Equity Securities up to 10% of its issued capital over a period of 12 months after the Annual General Meeting ("10% Placement Capacity"). The Company is an Eligible Entity.

If Shareholders approve this resolution, the number of Equity Securities the Company may issue under the 10% Placement Capacity will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (as set out below).

The effect of this resolution will be to allow the Directors to issue Equity Securities up to 10% of the Company's fully paid ordinary securities on issue under the 10% Placement Capacity during the period up to 12 months after the Annual General Meeting, without subsequent shareholder approval and without using the Company's 15% annual placement capacity under ASX Listing Rule 7.1.

This resolution is a special resolution. Accordingly, at least 75% of votes cast by shareholders present and eligible to vote at the Annual General Meeting must be in favour of this resolution for it to be passed.

ASX Listing Rule 7.1A

ASX Listing Rule 7.1A came into effect on 1 August 2012 and enables an Eligible Entity to seek shareholder approval at its Annual General Meeting to issue Equity Securities in addition to those under the Eligible Entity's 15% annual placement capacity.

An Eligible Entity is one that, as at the date of the relevant Annual General Meeting:

• (a) is not included in the S&P/ASX 300 Index; and
• (b) has a maximum market capitalization (excluding restricted securities and securities quoted on deferred settlement basis) of \$300,000,000.

The Company is an Eligible Entity as it is not included in the S&P/ASX 300 Index and has a current market capitalisation less than \$300,000,000.

Any Equity Securities issued must be in the same class as an existing class of quoted Equity Securities. The Company currently has two classes of Equity Securities on issue, being fully paid ordinary shares in the capital of the Company ("Shares") (ASX Code: CAN) and Underwriter Options (unlisted).

The exact number of Equity Securities that the Company may issue under an approval under ASX Listing Rule 7.1A will be calculated according to the following formula:

(A x D) - E

Where:

A: is the number of Shares on issue 12 months before the date of issue or agreement:

• (A) plus the number of Shares issued in the previous 12 months under an exception in ASX Listing Rule 7.2;
• (B) plus the number of partly paid Shares that became fully paid in the previous 12 months;
• (C) plus the number of Shares issued in the previous 12 months with approval of holders of Shares under ASX Listing Rules 7.1 and 7.4; and
• (D) less the number of Shares cancelled in the previous 12 months.

E: is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the 12 months before the date of issue or agreement to issue that are not issued with the approval of holders or Shares under ASX Listing Rule 7.1 or 7.4.

Technical information required by ASX Listing Rule 7.1A

Pursuant to and in accordance with ASX Listing Rule 7.3A, the information below is provided in relation to this resolution.

(a) Minimum Price

The minimum price at which the Equity Securities may be issued is 75% of the volume weighted average price of Equity Securities in that class, calculated over the 15 ASX trading days on which trades in that class were recorded immediately before:

• (i) the date on which the price at which the Equity Securities are to be issued is agreed; or
• (ii) if the Equity Securities are not issued within 5 ASX trading days of the date on which the price at which the Equity Securities are to be issued is agreed, the date on which the Equity Securities are issued.

(b) Date of Issue

The Equity Securities may be issued under the 10% Placement Capacity commencing the date of this Annual General Meeting and expiring on the first to occur of the following:

• (i) 12 months after the date of this Annual General Meeting; and
• (ii) the date of approval by shareholders of any transaction under ASX Listing Rules 11.1.2 (a significant change to the nature or scale of the Company's activities) or 11.2 (disposal of the Company's main undertaking).

or such longer period if allowed by ASX ("10% Placement Capacity Period").

(c) Risk of voting dilution

Any issue of Equity Securities under the 10% Placement Capacity will dilute the interests of shareholders who do not receive any Shares under the issue.

If the Resolution is approved by shareholders and the Company issues the maximum number of Equity Securities available under the 10% Placement Capacity, the economic and voting dilution of existing Shares is shown in the table below.

The table below seeks to demonstrate the potential dilution of existing shareholders resulting from the issue of Equity Securities under the 10% Placement Capacity calculated in accordance with the formula contained in Listing Rule 7.1A(2). The table does this by setting out the potential number of Shares issued and funds raised on the basis of:

• (i) the current number of Shares on issue;
• (ii) the number of Shares on issue changing (variable 'A' in the formula); and
• (iii) a variation in the issue price of the Shares (noting that Shares may only be issued at up to a 25% discount based on the volume weighted average price of the Shares calculated over the 15 ASX trading days preceding the issue).

D: is 10%.

Number of Shares on issue - Variable 'A' in Listing Rule 7.1A.2		Dilution
		\$0.525 50% decrease in Issue Price	\$1.05 Current Issue Price	\$2.10 100% increase in Issue Price
Current Shares on issue 141,871,785 Shares	Additional 10% Shares issued	14,187,179	14,187,179	14,187,179
	Funds raised	\$7,448,269	\$14,896,538	\$29,793,076
50% increase * 212,807,678 Shares	Additional 10% Shares issued	21,280,768	21,280,768	21,280,768
	Funds raised	\$11,172,403	\$22,344,806	\$44,689,613
100% increase *	Additional 10% Shares issued	28,374,357	28,374,357	28,374,357
283,743,570 Shares	Funds raised	\$14,896,538	\$29,793,075	\$59,586,150

*The number of Shares on issue (variable A in the formula) could increase as a result of Shares that do not require shareholder approval to be issued (such as under a pro-rata rights issue, Shares issued under a takeover offer or Shares issued on the exercise of options) or that are issued with shareholder approval under ASX Listing rule 7.1.

The table above uses the following assumptions:

• 1. The current number of Shares on issue is the Shares on issue as at 29 October 2019.
• 1. The current issue price set out above is the closing price of the Shares on the ASX on 24 October 2019.
• 1. The Company issues the maximum possible number of Equity Securities under the 10% Placement Capacity.
• 1. The Company has issued 158,802 Equity Securities in the 12 months prior to this Annual General Meeting that were issued under ASX Listing Rule 7.1 and a resolution to ratify that issue of Shares is contained in Resolutions 5 and 6.
• 1. The calculations above do not show the dilution that any one particular Shareholder will be subject to. All Shareholders should consider the dilution caused to their own shareholding depending on their specific circumstances.
• 1. This table does not set out any dilution pursuant to approvals under ASX Listing Rule 7.1.

Shareholders should note that there is a risk that:

• (i) the market price for the Company's Shares may be significantly lower on the issue date than on the date of this Annual General Meeting; and
• (ii) the Shares may be issued at a price that is at a discount to the market price for those Shares on the date of issue.

Purpose of Issue under 10% Placement Capacity

The Company may issue Equity Securities under the 10% Placement Capacity for various purposes including the following:

• (i) a cash issue price, in this case, the Company may use the funds for acquisition of new assets or investments (including expenses associated with such acquisitions or investments), working capital or for other corporate purposes; or
• (ii) non-cash consideration, such as for the acquisition of new assets or investments, subject to any applicable ASX requirements. In such circumstances, the Company will provide a valuation of the non-cash consideration as required by ASX Listing Rule 7.1A.3.

Allocation under the 10% Placement Capacity

The Company's allocation policy is dependent on the prevailing market conditions at the time of any proposed issue under the 10% Placement Capacity. The identity of the allottees under the 10% Placement Capacity will be determined on a case by case basis having regard to the factors including the following:

• (i) the purpose of the issue;
• (ii) alternative methods of raising funds available to the Company at that time, including, but not limited to, an entitlement issue or other offer where existing Shareholders may participate;
• (iii) the effect of the issue of the Equity Securities on the control of the Company;
• (iv) the circumstances of the Company, including, but not limited to, the financial position and solvency of the Company;
• (v) prevailing market conditions; and
• (vi) advice from corporate, financial and broking advisors (if applicable).

The allottees under the Additional 10% placement have not been determined as at the day of finalisation of this Notice of Annual General Meeting and may include existing substantial shareholders and/or new shareholders. However, the allottees cannot include any directors, related parties or associates of a related party of the Company without further specific shareholder approval.

Previous Approval

The Company has not previously obtained shareholder approval under ASX Listing Rule 7.1A.

Special Resolution

This resolution is a special resolution. Accordingly, at least 75% of votes cast by shareholders present and eligible to vote at the Annual General Meeting must be in favour of this resolution for it to be passed.

Voting Exclusion

A voting exclusion statement is included in this Notice of Annual General Meeting. As at the date of this Notice of Annual General Meeting, the Company has not invited any existing shareholder to participate in an issue of Equity Securities under ASX Listing Rule 7.1A. Therefore, no existing shareholders will be excluded from voting on this resolution.

The Directors understand that many eligible companies have sought this form of shareholder approval to enable a capital raising to be implemented where appropriate during the following year, without incurring costs for obtaining shareholder approval or incurring any time delay for obtaining such approval.

Accordingly, shareholder approval of this resolution is considered to be a prudent approach. The Directors believe that this resolution will provide the Company with flexibility to raise capital quickly if advantageous terms are available, and is in the best interests of the Company.

The chairman of the meeting intends to vote undirected proxies in favour of this resolution.

Directors' Recommendation

The Directors unanimously recommend that shareholders vote in FAVOUR of this resolution.

LODGE YOUR VOTE

ONLINE www.linkmarketservices.com.au

BY MAIL Cann Group Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia

BY FAX

+61 2 9287 0309

BY HAND

Link Market Services Limited

1A Homebush Bay Drive, Rhodes NSW 2138; or

Level 12, 680 George Street, Sydney NSW 2000

ALL ENQUIRIES TO Telephone: +61 1300 554 474

X99999999999

PROXY FORM

I/We being a member(s) of Cann Group Limited and entitled to attend and vote hereby appoint:

APPOINT A PROXY

the Chairman of the Meeting (mark box)

OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the name of the person or body corporate you are appointing as your proxy

STEP 1or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy to act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent permitted by the law, as the proxy sees fit) at the Annual General Meeting of the Company to be held at 11:00am (Melbourne time) on Friday, 29 November 2019 at Exhibition Room at the offices of William Buck, Level 20, 181 William Street, Melbourne VIC 3000 (the Meeting) and at any postponement or adjournment of the Meeting. SAMPLE

Important for Resolution 2: If the Chairman of the Meeting is your proxy, either by appointment or by default, and you have not indicated your voting intention below, you expressly authorise the Chairman of the Meeting to exercise the proxy in respect of Resolution 2, even though the Resolution is connected directly or indirectly with the remuneration of a member of the Company's Key Management Personnel (KMP).

The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business.

VOTING DIRECTIONS

Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting. Please read the voting instructions overleaf before marking any boxes with an T

	Resolutions For	Against Abstain*	For Against Abstain*
	2 Adoption of Remuneration Report	6 Ratify the issue of 67,538 Shares under Listing Rule 7.1
P 2 STE	Re-election of Director - 3 Mr Allan McCallum	Approval of Long-Term Incentive 7 Plan
	4 Re-election of Director - Mr Douglas Rathbone	8 Approval of 10% placement capacity for 12 months
	5 Ratify the issue of 91,164 Shares under Listing Rule 7.1
	 votes will not be counted in computing the required majority on a poll.		* If you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your
	SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED
	Shareholder 1 (Individual)	Joint Shareholder 2 (Individual)	Joint Shareholder 3 (Individual)
P 3
STE	Sole Director and Sole Company Secretary	Director/Company Secretary (Delete one)	Director

This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder's attorney, the power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be executed in accordance with the company's constitution and the Corporations Act 2001 (Cth).

CAN PRX1901C

YOUR NAME AND ADDRESS

This is your name and address as it appears on the Company's share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes. Please note: you cannot change ownership of your shares using this form.

APPOINTMENT OF PROXY

If you wish to appoint the Chairman of the Meeting as your proxy, mark the box in Step 1. If you wish to appoint someone other than the Chairman of the Meeting as your proxy, please write the name of that individual or body corporate in Step 1. A proxy need not be a shareholder of the Company.

DEFAULT TO CHAIRMAN OF THE MEETING

Any directed proxies that are not voted on a poll at the Meeting will default to the Chairman of the Meeting, who is required to vote those proxies as directed. Any undirected proxies that default to the Chairman of the Meeting will be voted according to the instructions set out in this Proxy Form, including where the Resolution is connected directly or indirectly with the remuneration of KMP.

VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT

You may direct your proxy how to vote by placing a mark in one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid. SAMPLE

APPOINTMENT OF A SECOND PROXY

You are entitled to appoint up to two persons as proxies to attend the Meeting and vote on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by telephoning the Company's share registry or you may copy this form and return them both together.

To appoint a second proxy you must:

(a) on each of the first Proxy Form and the second Proxy Form state the percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and

(b) return both forms together.

SIGNING INSTRUCTIONS

You must sign this form as follows in the spaces provided:

Individual: where the holding is in one name, the holder must sign.

Joint Holding: where the holding is in more than one name, either shareholder may sign.

Power of Attorney: to sign under Power of Attorney, you must lodge the Power of Attorney with the registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please indicate the office held by signing in the appropriate place.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate "Certificate of Appointment of Corporate Representative" must be produced prior to admission in accordance with the Notice of Meeting. A form of the certificate may be obtained from the Company's share registry or online at www.linkmarketservices.com.au.

LODGEMENT OF A PROXY FORM

This Proxy Form (and any Power of Attorney under which it is signed) must be received at an address given below by 11:00am (Melbourne time) on Wednesday, 27 November 2019, being not later than 48 hours before the commencement of the Meeting. Any Proxy Form received after that time will not be valid for the scheduled Meeting.

Proxy Forms may be lodged using the reply paid envelope or:

ONLINE

www.linkmarketservices.com.au

Login to the Link website using the holding details as shown on the Proxy Form. Select 'Voting' and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their "Holder Identifier" - Securityholder Reference Number (SRN) or Holder Identification Number (HIN).

BY MAIL

Cann Group Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia

BY FAX

BY HAND

+61 2 9287 0309

delivering it to Link Market Services Limited* 1A Homebush Bay Drive Rhodes NSW 2138 or Level 12 680 George Street Sydney NSW 2000

* During business hours (Monday to Friday, 9:00am–5:00pm)

IF YOU WOULD LIKE TO ATTEND AND VOTE AT THE ANNUAL GENERAL MEETING, PLEASE BRING THIS FORM WITH YOU. THIS WILL ASSIST IN REGISTERING YOUR ATTENDANCE.